University of Patras
Επίδραση της επαγόμενης από σηματοδοτικό μονοπάτι Wnt-1, πρωτεϊνης-1 (Wisp-1) στην έκφραση του παράγοντα αναστολής της μετανάστευσης μακροφάγων (MIF) σε ινοβλάστες από ασθενείς με διάφορες νόσους του συνδετικού ιστού και ο ρόλος της στην παθογένεια των νόσων αυτών
Abstract
dc:descriptionIntroduction: Osteoarthritis (OA) is the most common degenerative disease of the synovial joint, including the degradation of articular cartilage, subchondral bone sclerosis, abnormal bone remodeling, osteophyte formation, and chronic inflammation of the synovial membrane. The exact etiology of OA is not well understood. The synovial membrane is responsible for the inflammatory reaction leading to macrophage derived proinflammatory cytokines, such as IL-1β, IL-6, IL-8 and TNF-α, that promote inflammation, neovascularization and cartilage degradation via activation of proteolytic enzymes, such as matrix metalloproteinases (MMPs). The principal forms of OA treatment include pain management and replacement surgery (total arthroplasty). However, eight to ten years after the total arthroplasty, loosening of inserted prostheses is usually observed. A cascade of mechanical and biological events take place, involving the fragmentation and wear of the implanted materials and subsequently the release of implant particles into the periprosthetic tissues, evoking a foreign-body reaction and activation of cells to produce a variety of cytokines, growth factors and proteolytic enzymes. These cell products cause, through complex mechanisms, periprosthetic osteolysis that exceeds the reparative capacity of the fibrous and osseous tissues, resulting in loosening of the implant. Pterygium is an eye disorder featuring hyperplasia of the cornea epithelium, overgrowth of stromal fibroblasts and blood vessels, significant neovascularization, inflammatory cell infiltration and abnormal extracellular matrix accumulation, with elastin and collagen to be the main components. Histopathological studies revealed that the pterygium epithelium, which invades the cornea, exhibits alterations such as squamous metaplasia and goblet cell overgrowth. The exactly reasons of pterygium pathogenesis remain unclear, however the ultraviolet (UV) radiation is considered to be the most acceptable reason of initiation of this disorder. Nasal polyposis (NP) is a chronic inflammatory disease of the upper airways, featuring inflammatory cell infiltration, modifications of epithelial differentiation, and tissue remodeling, including basement membrane thickening, gland modifications, extracellular matrix (ECM) accumulation and oedema. It has been reported that polyp formation involves ECM swelling through an initial localized epithelial injury. Interactions between epithelial, stromal and inflammatory cells could then perpetuate further polyp growth. Mucosal inflammation, especially containing an infiltration of eosinophils, is probably the most important factor in the development of nasal polyposis. Various mediators, including cytokines, chemokines, growth factors, adhesion molecules and proteolytic enzymes are found in pterygium and polyp stroma, and some of these mediators participate in a series of events that culminate in chronic inflammation and the subsequent development of these diseases. The lung is the primary organ of the respiratory system, composed of specialized cell types that provide structure and perform the necessary tasks for the lung to function properly. Every day, together with breath air, airborne particles are entered that can injure the lung, which in many cases do not come out again during exhalation. In healthy conditions, these threats do not necessarily cause a problem due to the fact that the lung has evolved to balance responses to maintain homeostasis, whereby it responds efficiently to threats without causing an exaggerated response that hampers the respiratory process. However, when the threat becomes repetitive and/or when the conditions alter basic cell functions (e.g., aging, genetic predispositions, immune disorders), the response of the lung to tissue damage becomes distorted and may lead to several chronic lung diseases, including COPD, asthma, pulmonary fibrosis, lung cancer, and pulmonary hypertension.Idiopathic pulmonary fibrosis (IPF) is characterized by formation of fibroblast foci and deposition of extracellular matrix (ECM) in the lung interstitium. This results in distorted lung architecture, impaired gas exchange and reduced respiratory function. Impaired crosstalk between alveolar type 11 (AT11) cells and subepithelial fibroblasts has previously been shown to contribute to ECM deposition in IPF.COPD is one of the most common chronic lung diseases, and, according to the World Health Organization (WHO), is the fourth cause of death worldwide. The primary cause of COPD is exposure to cigarette smoke and/or air pollution. The pathogenesis of COPD develops as an exaggerated inflammation in response to cell damage caused by the repetitive exposure to toxic components such as those found in cigarette smoke or air pollution. Exposure of lung epithelial cells to these toxic agents leads to epithelial cell injury. Because of the repetitive nature of the toxic exposure, persistent inflammatory and repair responses may occur, leading to the overall destruction of lung tissue, known as emphysema, and to airway fibrosis associated with chronic bronchitis.Asthma is a chronic inflammatory disease, affecting children and adults, characterized by airway obstruction and bronchial hyperresponsiveness. Asthma is thought to develop as a complex gene-environment interaction in response to allergens, pollutants, microbes, and/or oxidative stress. All the different endotypes of asthma are characterized by airway hyperresponsiveness, a consequence of immune and physiological responses to allergens or pollutants. The immune response may include activation of eosinophils, neutrophils, dendritic cells, macrophages, mast cells, and CD4 positive T cells. Another distinctive pathophysiological feature of asthma is airway remodeling, characterized by thickening of the basement membrane, an increase in airway smooth muscle mass, bronchial epithelium damage and cilial dysfunction, goblet cell hyperplasia, and increased mucus production.Macrophage migration inhibitory factor (MIF) is a conserved protein found across eukaryotes, which in mammals is known by its function as a pleiotropic cytokine. Unlike most cytokines, MIF has enzymatic activity as a phenylpyruvate tautomerase and D-dopachrome tautomerase (DDT). MIF has been shown to be involved in a wide range of diseases such as cancer, atherosclerosis, diabetes, and several inflammatory conditions. MIF induces a wide range of effects by different modes of action. Its function is mostly proinflammatory with chemokine-like properties via binding and activation of complex CD74/CD44 receptors found in a variety of tissues, initiating cytokine release and cell proliferation. MIF has a significant role in the innate immune defense against acute viral and bacterial infection, tuberculosis, and protozoan diseases. In addition to these functions, MIF has a unique feature by its induction by glucocorticoids, in which MIF is one of a few mediators with the ability to antagonize the anti-inflammatory effect of glucocorticoids.MIF has been identified in RA and OA fluid, serum and synovial fibroblasts. It has been demonstrated in vitro induction by MIF of molecules and processes relevant to RA and OA, including FLS proliferation and expression of pro-inflammatory genes including phospholipase A2, cyclooxygenase-2, prostaglandin E2 TNF-α, IL-1β, IL-2, IL-6 and IL-8. In addition, MIF up-regulates MMP-1 and MMP-3 expression in synovial FLS in vitro and these molecules are important in tissue remodeling and may be crucial to cartilage injury. MIF has been also identified in nasal polyp and eye pterygium.MIF has been associated with several chronic lung diseases, including COPD, asthma, pulmonary fibrosis, lung cancer, and pulmonary hypertension. In the lungs, MIF can be found in macrophages, lymphocytes, eosinophils, and the capillary endothelium. Increased MIF levels have been measured in both bronchial alveolar lavage and serum in patients with asthma. Raised MIF values has also been observed in acute respiratory distress syndrome (ARDS), obstructive sleep apnea, and idiopathic pulmonary fibrosis. The activated β-catenin, through Wnt canonical pathway, directly promotes the transcription of a variety of Wnt/β-catenin signaling effectors, including WNT1-inducible signaling pathway protein 1 (WISP1/CCN4). WISP-1/CCN4 is a secreted matricellular protein that belongs to the CCN family. Except for WISP-2, all CCN proteins contain a short N-terminal signal peptide, followed by four conserved structural domains (IGFBP, VWC, TSP, and CT) to mediate their interactions with extracellular proteins and cell surface receptors. WISP-1do not interact with specific membrane receptors, but it binds multiligand receptors, primarily integrins, to regulate the intracellular signaling. WISP-1 is able to activate a variety of downstream signaling, including focal adhesion kinase (FAK), RAS/RAF/MEK/ERK, NF-κB, TGF-β, and PI3K/AKT pathways. Functionally, WISP-1-initiated signals regulate various biological processes, including cell adhesion, proliferation, differentiation, survival, motility, and wound healing/tissue repair. In vitro binding assays and functional assays with integrin blocking antibodies indicated that α5β1, αvβ3, and αvβ5 integrins were involved in WISP-1 signaling, and these integrins were essential for WISP-1-induced activation of FAK, Rac, RAS/RAF/MEK/ERK, JNK, or NF-κB pathways in epithelial cells, fibroblasts, bone marrow stromal cells, or cancer cells. It has been previously demonstrated that WISP-1 is implicated in OA pathogenesis, as well as in lung diseases, including COPD, asthma and pulmonary fibrosis. On the other hand, there are not evidences regarding the implication of WISP1 in arthroplasty endoprostheses loosening, nasal polyp and pterygium. In addition, there are not also evidences about the association of WISP-1 with MIF and vice-versa.AimThe aim of the present work is the study of the Wnt-1 / WISP-1 signaling pathway and its ability to induce the expression of MIF and various other extracellular matrix molecules, such as cytokines and proteolytic enzymes in primary cultures of fibroblasts from synovial membrane (SM) of patients with osteoarthritis, periprosthetic membrane from loose arthroplasty endoprostheses (IFT), nasal polyp (NP), eye pterygium (EP) and normal lung fibroblasts (NL).MethodsFibroblasts were isolated from SM, IFT, NP, EP and NL tissues upon mild treatment with clostridium collagenase. The cells were cultured in DMEM with WISP-1, in the absence or presence of several inhibitors and other factors tested. In all the experiments, fibroblasts of at least 4th passage were used. The techniques used were ELISA, western blotting, qPCR and immunohistochemistry. Results It has been previously reported that WISP-1 and MIF is highly expressed in SM from patients with OA, as well as in the lung of patients with various lung diseases, such as IPF, COPD and asthma, and may be implicated in the pathogenesis of these disorders. In addition, it was known that MIF is also expressed in IFT, nasal polyp and pterygium. Using qPCR and western blotting it was ascertain that WISP-1is present also in IFT, nasal polyp and pterygium.Immunohistochemistry study, using specific antibodies against human WISP-1and MIF, revealed that both, WISP-1 and MIF are highly co-expressed in epithelial cells of SM, nasal polyp and pterygium, and in giant cells in IFT. Immunostaining for MIF was also observed in stromal cells of all tissues tested. Treatment of fibroblasts with WISP-1 at various concentrations enhanced MIF production in a concentration- and time-dependent fashion. In WISP-1-enhanced MIF production the αvβ5 integrin and dermatan sulphate proteoglycans, as well as the MAP kinases, PI3-K/Akt, PKC, FAK, cAMP/EPAC and NF-κB signalling pathways are involved. WISP-1-enhanced MIF expression was also attenuated in the presence of the src-kinase inhibitor PP2 or in the presence of ISO-1, an inhibitor of MIF tautomerase activity. It was also found that WISP-1-enhanced MIF expression involves EGFR after its transactivation by src kinases, which are previously activated by the effect of WISP-1.WISP-1 was also able to enhance the expression of CD74 and CD44, through of which MIF exerts its effects on cells. In addition, it was ascertain that WISP-1 was also able to promote the cells migration and to enhance the expression of IL-6, of COX-2 and PGE2 production, and the production of matrix metalloproteinases, MMP-1, MMP-2, MMP-3 and MT1-MMP. These effects of WISP-1 are mediated by MIF, as shown. Quercetin, an isoflavone with antioxidant properties, was able to suppress the WISP-1-enhanced expression of both MIF and IL-6. ConclusionsIt appear that, WISP-1, in addition of its implication in pathogenesis of OA and various lung diseases, may be also implicated in the pathogenesis of arthroplasty loosening, nasal polyp and eye pterygium, which it is reported for the first time. WISP-1, by the mediation of various factors, mainly of integrin αvβ5, FAK/src kinases, EGFR, PKC and NF-κB, up-regulates the expression of MIF in a variety of fibroblasts of different origin. MIF then, through the complex of its receptor/co-receptor, CD74/CD44, activates src kinases. The src kinases can also be activated by PGE2, the production of which is enhanced by MIF. Thereafter, src kinases trans-activate EGFR leading in the enhancement of expression of MIF itself and IL-6, as well as in the enhancement of MMPs production.To be concluded, the implication of WISP-1 in pathogenesis of several diseases, such as, OA, arthroplasty loosening, nasal polyp, eye pterygium and lung diseases may be mediated at least in part by MIF of which the expression it enhances.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Christopoulou, Maria-Elpida
- Χριστοπούλου, Μαρία-Ελπίδα
Subjects
dc:subject × 29- Πνεύμονας
- Οστεοαρθρίτιδα
- Κυτταρική σηματοδότηση
- Εξωκυττάρια μήτρα
- Χρόνιες φλεγμονώδεις παθήσεις
- Παράγοντας αναστολής της μετανάστευσης των μακροφάγων
- Πρωτογενείς καλλιέργειες κυττάρων
- Ινοβλάστες
- Lung
- Osteoarthritis
- Cell signalling
- Extracellular matrix
- Chronic inflammatory diseases
- MIF
- WISP-1
- Primary cell cultures
- Fibroblasts
- Χημεία
- Φυσικές Επιστήμες
- Χημεία, άλλοι τομείς
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Chemical Sciences
- Natural Sciences
- Chemistry, miscellaneous
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51204